Methods for integration of pharmacokinetic and phenotypic information in the treatment of infection with human immunodeficiency virus.
Interest in monitoring antiretroviral drug concentrations in human immunodeficiency virus-infected patients has gained considerable momentum in recent years. We present a potential method for integrating pharmacokinetic and phenotypic information that will assist clinicians in choosing optimal treatment regimens for their patients and that will provide an approach for the interpretation of antiretroviral plasma drug concentrations.
Acosta
Edward P
EP
Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, AL 35294-0019 , USA. EAcosta@uab.edu
King
Jennifer R
JR
D019380:Anti-HIV Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004358:Drug Therapy / Q000379:methods*; D006678:HIV; D015658:HIV Infections / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D010641:Phenotype
D019380:Anti-HIV Agents